The Recombinate study group: A multicenter study of recombinant factor VIII (Recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A - Bray, GL; Gomperts, ED; Courter, S; Gruppo, R; Gordon, EM; Mancho-Johnson, M; Shapiro, A; Scheibel, E; White III, G; Lee, M (Blood, 1994)